Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (6)

2022

  1. Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension

    Multiple Sclerosis Journal, Vol. 28, Núm. 3, pp. 480-486

2021

  1. A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology

    European Journal of Neurology, Vol. 28, Núm. 11, pp. 3849-3855

  2. EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic

    European Journal of Neurology, Vol. 28, Núm. 1, pp. 7-14

  3. Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis

    Neurology, Vol. 96, Núm. 24, pp. E2989-E3002

  4. Primary prevention of COVID-19: Advocacy for vaccination from a neurological perspective

    European Journal of Neurology

2020

  1. The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection

    European Journal of Neurology, Vol. 27, Núm. 9, pp. 1727-1737